Skip to main content
Main navigation
About pCPA
Who We Are
Governance
Strategic Plan
Reports
What's New at the pCPA
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Erleada (apalutamide)
pCPA File Number:
21241
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Castration-Sensitive Prostate Cancer
Sponsor/Manufacturer:
Janssen Inc.
CADTH Project Number:
pCODR 10200
pCPA Engagement Letter Issued:
2020-10-09
Negotiation Process Concluded:
2021-08-17